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Abstract: 
Finding the ultimate HIV cure remain a challenging tasks for decades. Various active compounds have been tested against various 
components of the virus in the effort to halt the virus development in infected host. The idea of finding cure from known 
pharmacologically active natural occurring compounds is intriguing and practical. Ganoderma lucidum (Ling-Zhi or Reishi) is one 
of the most productive and pharmacologically active compounds found in Asian countries. It has been used traditionally for many 
years throughout different cultures.  More than a decade ago, el-Mekkawy and co-workers (1998) have tested several active 
compounds found in this plant. They have successfully identified several active compounds with reasonable inhibitory activity 
against HIV protease however; no further studies were done on these compounds. This study aimed to elucidate interactions for 
one of the active compounds of Ganoderma lucidum namely ganoderic acid with HIV-1 protease using molecular docking 
simulation. This study revealed four hydrogen bonds formed between model34 of ganoderic acid B and 1HVR. Hydrogen bonds in 
1HVR-Model34 complex were formed through ILE50, ILE50’, ASP29 and ASP30 residues. Interestingly similar interactions were 
also observed in the native ligand in 1HVR. Furthermore, interactions involving ILE50 and ILE50’ residues have been previously 
identified to play central roles in HIV-1 protease-ligand interactions.These observed interactions not only suggested HIV-1 protease 
in general is a suitable target for ganoderic acid B, they also indicated a huge potential for HIV drug discovery based on this 
compound. 
 
 
Background: 
Ganoderma lucidum are filamentous fungi come from 
Basidiomycota phylum and Ganodermataceae family. It has 
been used extensively as home remedy in traditional 
Chinese medicine in many Asian countries for 2000 years. G. 
lucidum also known as Ling-Zhi in China and Korea and 
R e i s h i  o r  M a n n e n t a k e  i n  J a pan - has received wide of 
attention in recent year due to its extraordinarily 
pharmacological functions [1]. The pharmacological effect of 
G. lucidum is based on their powerful immune-modulating 
activity and immune potential capability which support and 
enhance the immune system due to 200 active elements from 
fruiting body, mycelia, spores and anther. The active 
elements can be categorized into water soluble, organic 
soluble and volatile soluble compounds and include 
polysaccharide, polysaccharide-peptide complex, β-glucans, 
lectins, organic germanium, adenosine, triterpenoids and 
nucleosides  [2, 3]. Triterpenoids are common chemical 
constituent of G. lucidum. However, due to their unique 
properties, the importance of triterpenoids is established not 
only within the species but also extends to the 
chemotaxonomy of Ganoderma genus [4]. Recently, more 
than 140 different triterpenoids have been isolated and 
characterized with ganoderic acids as one of the main 
triterpenoids present in G. lucidum [2, 3]. Ganoderic acid is 
highly oxygenated lanostane-type triterpenoids and due to 
its valuable medicinal of pharmacological values, a lot of 
s t u d i e s  h a v e  b e e n  d o n e  o n  p r o c e s s  d e v e l o p m e n t  i n  BIOINFORMATION  open access 
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enhancing production of ganoderic acid [1]. Most identified 
ganoderic acids are named using Latin or Greek alphabets 
along with numbering systems. 
Biological effects of ganoderic acids as reported in the 
literature were antitumor, anti-HIV, antihypertensive, 
antihepatotoxic, anti-inflammation, inhibition of histamine 
release, hypocholesterolemic, anti-complement, 
antinociceptive, antioxidant, antiaging activities and platelet 
aggregation effects [5, 6, 7, 8, 9, 10, 11, 12,]. More than a 
decade ago, El-Mekkawy and co-workers [6] have tested 
active compounds from Ganoderma lucidum against HIV 
proliferation and HIV protease. They have successfully 
identified thirteen compounds with inhibitory activities 
against HIV protease (HIV-PR) and proliferation of HIV-1 
from G lucidum. Five of those compounds belong to 
ganoderic acid family namely ganoderic acid A, B, C1, H and 
α. Today, it is a common practice to utilize molecular 
modelling to complement conventional wet lab research 
especially in the field of drug discovery. Molecular 
modelling such as molecular docking and reverse docking 
has developed by leaps and bounds in the last decades in 
terms of technology and computing power. Emergence of 
this field has open new possibilities and ways to learn 
molecular interaction between molecules.Molecular docking 
can be described as the process of docking a small molecule 
(ligand, inhibitor and etc.) to a macromolecule with the 
objective of observing and studying interactions between 
these molecules. Reverse docking can be described as the 
process of searching a small molecule-protein target over a 
large database of potential protein targets. In contrast to 
conventional docking approach, reverse docking screens the 
molecule against specific database. The reverse docking 
terms rooted from the fact that this approach starts from the 
molecule of interest (usually ligands) whilst in conventional 
molecular docking usually starts with the potential targets 
(the proteins). From HIV drug development perspective, a 
combination of molecular modelling tools namely molecular 
dynamics and molecular docking has led to the discovery of 
the first HIV-integrase inhibitor. Previously, these methods 
have successfully pointed out a previously unidentified 
region in HIV-integrase and this region later on became a 
potent target for HIV-integrase inhibitor [13]. This report 
aims to study molecular perspective of interaction for 
ganoderic acid compounds with HIV inhibitory activity as 
identified by el-Mekkawy and co-workers [6] using 
molecular docking simulation. Ganoderic acid compounds 
with HIV inhibitory activity were studied using two 
molecular docking approaches (reverse molecular docking 
and molecular docking). Outcomes from these docking 
studies are reported here. 
  
Methodology: 
Compound of interest were identified from previous work 
by el-Mekkawyand co-workers [6]. Four compounds with 
IC50 ranging from 0.17 mM to 0.20 mM were chosen as the 
compound of interest.They are ganoderic acid α (0.19 mM), 
ganoderic acid B (0.17 mM), ganoderic acid C1 (0.18 mM) 
and ganoderic acid H (0.20 mM). Three dimensional 
structures of these compounds were obtained from 
PubChem database [14]. All four structures were submitted 
to TarFisDock server [15] against the Potential Drug Target 
Database (PDTD) [16] for target identification by reverse 
docking. Viral infections were selected as the target criteria 
and default parameters defined in the server were used. 
Targets were selected and filtered based on their match with 
pharmacology activities as found in literatures, the crystal 
structure resolution and distribution in regards to 
compounds of interest. These selected protein targets were 
subsequently used in molecular docking studies where their 
three dimensional structure files were downloaded from the 
RCSB Protein Data Bank [17]. All docking studies were 
performed using the Autodock 4 and ADT suite program 
[18]. Hydrogen atoms, Gasteiger charges and torsion angles 
were computed and added to the ganoderic acid compounds 
(ganoderic acid α, B, C1, and H). For macromolecules, all 
water molecules and ligand were removed prior preparing 
the input files. Hydrogen atoms and Gasteiger charges were 
computed and added to the macromolecules. Active site of 
the target was highlighted and 50x60x60 grid box with 
0.375Å grid spacing was drawn to cover the active site of the 
target. Each docking trial was initiated with 100 runs. 
Population size, energy evaluations, mutation and crossover 
rates and local search probability were kept as default. 
Molecular docking results were analyzed by cluster number, 
and hydrogen bonding comparison with the target’s native 
ligand. 
 
Discussion: 
Reverse Docking 
Based on the results by TarFisDock, two types of HIV target 
proteins were identified forboth ganoderic acid α (HIV-1 
Reverse Transcriptase, HIV Protease) and ganoderic acid C1 
(HIV Protease, HIV-1 Integrase). On the other hand, only 
HIV Protease was identified for both ganoderic acid B and 
ganoderic acid H. This is in good agreement with studies 
carried out by el-Mekkawy and co-workers [6] where they 
also demonstrated inhibition of HIV Protease by ganoderic 
acid  α, B, C1 and H. Based on these potential targets 
resolution, their distribution with regard to compounds of 
interest and by correlation to el-Mekkawy and co-workers’ 
findings, 1DIF and 1HVR (both are HIV-1 Protease) were 
selected as target for further molecular docking analysis. 
 
 
Figure 1: (A) Hydrogen bond networks as shown in 1HVR-
Model 31 complex, 1HVR-Model 34 com-plex, 1HVR-native BIOINFORMATION  open access 
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ligand (XK2) complex. (B) Schematic representation of 
ganoderic acid B and XK 
 
Molecular Docking 
Summary of molecular docking results are shown in Table 1. 
(See supplementary material) Ganoderic acid B scored the 
lowest cluster number in both docking studies of 1HVR and 
1DIF. Interestingly, this compound also scored the lowest 
mean estimated ΔG (-8.83 Kcal/mol) and with 78% of cluster 
dominance in the molecular docking study of 1HVR. 
Furthermore this results was also consistent to the previous 
data from el-Mekkawy and co-workers [6] where the lowest 
IC50 (0.17 mM) were obtained f r o m  g a n o d e r i c  a c i d  B .  
Cluster number, mean estimated ΔG and percentage of 
dominant cluster can be employed as comparative tools to 
asses molecular docking results. Cluster number represents 
variance of the docked structure, mean estimated ΔG 
represents energy state of each structure and percentage of 
dominant cluster represents the simulated structure 
dominance. Low cluster number, mean estimated ΔG and 
high percentage of dominant cluster are desirable in 
molecular docking simulation. Molecular docking of 
ganoderic acid B and 1HVR returned better results as 
compared to 1DIF, both in cluster number and mean 
estimated  ΔG as compared to other docking studies. This 
makes ganoderic acid B an ideal candidate for further 
molecular interactions studies. Molecular interactions were 
studied in the best two conformations of molecular 
dockingstudies of 1HVR-ganoderic acid B. The first 
conformation was model 31 and the second conformation 
was model 34. Model 31 was the lowest scoring ΔG of all 
1HVR-ganoderic acid B docking runs. On the other hand 
model 34 was the lowest scoring ΔG in cluster 2 (the most 
dominant cluster) of 1HVR-ganoderic acid B docking.  
 
1HVR-Ganoderic acid B molecular interaction 
Summary of these hydrogen bond interactions is shown in 
Figure 1. Four hydrogen bonds were observed in 1HVR-
Model 34 complex.Amide hydrogen at ILE50 and ILE50’ 
formed two hydrogen bonds with oxygen atom at position 
29 of ganoderic acid B. Another hydrogen bond was 
observed between amide of ASP30 and oxygen atom at 
position 37. The last hydrogen bond was between amide 
hydrogen of ASP29 and hydroxyl at position 36. Four 
hydrogen bonds were also observed in the 1HVR-Model 31 
complex. Amide hydrogen at ILE50 formed hydrogen bond 
with oxygen atom at position 30. Amide hydrogen of ARG8 
formed two hydrogen bonds with oxygen atom at position 
37. The last hydrogen bond was between ASP25 and 
hydroxyl group at position 22. 
 
Interestingly similar hydrogen bonding patterns were also 
observed in the 1HVR native ligand (XK2) complex in the 
1HVR crystal structure. Two hydrogen bonds were observed 
between amide hydrogen of ILE50 and ILE50’ andoxygen 
atom position 7. Another two hydrogen bonds were from 
hydroxyl atoms position 26 and 27 with ASP25. Interaction 
of amide hydrogen for ILE50 and ILE50’, structural water 
molecule and the ligand or inhibitor through hydrogen bond 
is a common and a very important feature found in HIV-1 
protease  [19]. To further highlight the importance of this 
ILE50-ILE50’-ligand interactions, Lam and co-workers had 
designed their HIV-1 protease inhibitor solely based on this 
feature  [20]. The lack of structural water molecule in our 
docking studies is due to the limitation of the method where 
molecular docking wasperformed on simplified 
environment by removing all water molecules from the 
macromolecule, a common practice in molecular docking 
routine. Nevertheless, the strong interaction between ILE50, 
ILE50’ and ganoderic acid B can still be established and 
observed in this study. This finding illuminates the 
significance of ganoderic acid B might be a potential 
inhibitor for HIV-1 protease. 
 
Conclusions: 
Ganoderic acid B produced better molecular docking results 
compared to other ganoderic acid compounds. This is in 
good agreement with previous report where ganoderic acid 
B was reported to have the lowest IC50 [6]. Molecular 
interactions study revealed ganoderic acid B interactions 
with important residues of 1HVR, thus making 1HVR and 
HIV-1 protease in general suitable targets for this compound. 
The fact that ganoderic acid B is a naturally occurring 
compound and was found to interact with one of the most 
important feature of HIV-1 protease indicated a huge 
potential for HIV cure discovery based on this 
compound.More rigorous binding free energy calculation 
such as thermodynamics integration, free energy 
perturbation or molecular dynamic simulation as well as 
different vantage points such protonation state of the 
interacting molecules would be implemented in upcoming 
worksto obtain more in-depth information.  
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Supplementary material: 
 
Table 1: Summary of 1HVR and 1DIF molecular docking: 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
Compound  1HVR molecular docking  1DIF molecular docking   
IC50 
(mM) 
[6] 
Ganoderic 
acid α 
Mean  
estimated 
ΔG (Kcal 
mol-1) 
Lowest 
estimated ΔG 
(Kcal mol-1) 
Number 
of cluster 
% 
dominant 
cluster 
Mean  
estimated 
ΔG (Kcal 
mol-1) 
Lowest 
estimated ΔG 
(Kcal mol-1) 
Number 
of cluster 
% 
dominant 
cluster 
Ganoderic 
acid B 
-8.43 -9.71  12 42 -7.53 -8.63  15 45  0.19 
Ganoderic 
acid C1 
-8.83 -9.67 5 78 -6.99 -7.97 6 40  0.17 
Ganoderic 
acid H 
-8.63  -10.10 8 26 -8.13 -8.53 9 28  0.18 
Ganoderic 
acid α 
-7.02 -8.19  19 25 -6.59 -7.57  12 53  0.20 